161 related articles for article (PubMed ID: 31239235)
1. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
Williams KV; Becker DJ; Orchard TJ; Costacou T
J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
[TBL] [Abstract][Full Text] [Related]
2. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
9. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
[TBL] [Abstract][Full Text] [Related]
10. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
[TBL] [Abstract][Full Text] [Related]
11. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
[TBL] [Abstract][Full Text] [Related]
12. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
Lloyd CE; Becker D; Ellis D; Orchard TJ
Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
[TBL] [Abstract][Full Text] [Related]
13. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
[TBL] [Abstract][Full Text] [Related]
16. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
18. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
[TBL] [Abstract][Full Text] [Related]
19. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
[TBL] [Abstract][Full Text] [Related]
20. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]